⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 29, 2024Open Access

Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC

Yusuke Goto Keiichi Koshizuka Toshinori Ando Hiroki Izumi Xingyu Wu Kuniaki Sato Tomohiko Ishikawa Kyle Ford Xiaodong Feng Zhiyong Wang Nadia Arang Michael M. Allevato Ayush Kishore Prashant Mali J. Silvio Gutkind

View Full Paper

Ask AI

Bookmark

Share

Abstract

Combination therapy with INK128 and palbociclib is effective against HNSCC xenograft

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Goto et al. (2024) studied this question.

synapsesocial.com/papers/68e5eb36b6db643587580094 https://doi.org/10.1158/2767-9764.26392687

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC2024
2Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC2024
3Supplementary Figure 2 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC2024
4Supplementary Figure 2 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC2024
5Supplementary Figure 2 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC2024